Home › Guides › Pharmacy supervision legislation 2026

Pharmacy supervision legislation 2026 — what pharmacy owners need to know

The Human Medicines (Authorisation by Pharmacists and Supervision by Pharmacy Technicians) Order 2025 came into force in January 2026. Here is what it means for community pharmacy owners.

⚠ Important notice The information on this page is intended for general awareness only. It does not constitute professional advice and should not be acted upon without first consulting a qualified pharmacy compliance consultant. Regulations change — always seek specialist guidance before taking any action. Contact TI Pharmacy Consultancy for advice specific to your situation.
In summary: New pharmacy supervision legislation came into force on 7 January 2026, enabling pharmacists to authorise certain activities without being physically present and paving the way for registered pharmacy technicians to supervise dispensing activities. The changes are designed to free up pharmacist time for patient-facing clinical services. A one-year transition period applies to the pharmacy technician supervision provisions. This guide explains the key changes and what community pharmacy owners need to do.

What changed from 7 January 2026

The Human Medicines (Authorisation by Pharmacists and Supervision by Pharmacy Technicians) Order 2025 made two significant changes to the legal framework for pharmacy practice:

1. Pharmacist authorisation. Pharmacists can now authorise defined members of the pharmacy team to carry out certain activities without the pharmacist being physically present at the point those activities are performed. This is a significant change from the previous position, which required closer physical presence by the responsible pharmacist.

2. Pharmacy technician supervision. The legislation enables registered pharmacy technicians to supervise the preparation, assembly, dispensing and sale or supply of medicines. A one-year transition period applies to this element — the GPhC and the Royal Pharmaceutical Society are developing supporting standards and guidance during 2026.

The DHSC confirmed that the change coming into force on 7 January 2026 applies to NHS community pharmacies without any change to the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013.

Why this matters for pharmacy owners

The new legislation is designed to enable pharmacists to spend more time on patient-facing clinical services — consistent with the NHS’s ambition to expand Pharmacy First, advanced services and, from autumn 2026, Independent Prescribing within the CPCF. By enabling pharmacists to authorise activities without physical presence, the legislation allows a more flexible skill mix within the pharmacy team.

For pharmacy owners, the practical implications include: updating SOPs to reflect the new authorisation arrangements; ensuring that the pharmacy team understands which activities can be authorised and under what conditions; and preparing for the pharmacy technician supervision provisions when the supporting standards are published.

What pharmacy owners need to do

  • Ensure SOPs are updated to reflect the new authorisation arrangements from January 2026 — this is the pharmacy’s responsibility to action
  • Ensure staff are aware of which activities can now be authorised by pharmacists without physical presence
  • Monitor GPhC and RPS publications during 2026 for the supporting standards on pharmacy technician supervision
  • Plan for SOP updates when GPhC and RPS publish supporting standards — monitor publications during 2026
  • Ensure governance frameworks reflect the new arrangements
  • For Welsh pharmacies — verify the equivalent position with NHS Wales

England and Wales

The Order applies across Great Britain, including Wales. The GPhC, which regulates pharmacies in England, Wales and Scotland, is developing supporting standards applicable across all three nations. The DHSC confirmed that the January 2026 change applies to NHS community pharmacies in England. Welsh pharmacy owners should monitor NHS Wales guidance for confirmation of the equivalent position under the Welsh NHS framework.

Need help understanding the new supervision rules?

Contact TI Pharmacy Consultancy to discuss how the new supervision legislation affects your pharmacy and the compliance and governance steps you need to take.

Contact us Compliance services

Frequently asked questions

The Human Medicines (Authorisation by Pharmacists and Supervision by Pharmacy Technicians) Order 2025 is legislation approved by Parliament and the Privy Council that amends the Medicines Act 1968 and the Human Medicines Regulations 2012. It enables pharmacists to authorise certain activities without being physically present and enables registered pharmacy technicians to supervise the preparation, assembly, dispensing and sale or supply of medicines. The first stage came into force on 7 January 2026. A one-year transition period applies to the pharmacy technician supervision provisions.

From 7 January 2026, pharmacists can authorise certain members of the pharmacy team to carry out defined activities without the pharmacist being physically present at the point those activities are carried out. This enables pharmacists to devote more time to patient-facing clinical services — consistent with the expansion of Pharmacy First and advanced services. The Department of Health and Social Care confirmed that this change applies to NHS community pharmacies without any change to the NHS Terms of Service.

The Order allows a one-year transition period for the provisions enabling pharmacy technicians to supervise the preparation, assembly, dispensing and sale or supply of medicines. This transition period gives the GPhC and the Royal Pharmaceutical Society time to develop and publish supporting professional standards and guidance. Pharmacies should monitor GPhC and RPS publications during 2026 for the standards that will apply when the pharmacy technician supervision provisions come into full effect.

Yes. The new supervision arrangements require pharmacies to update their SOPs to reflect which activities can now be authorised by pharmacists without physical presence, and — when the transition period ends — which activities can be supervised by registered pharmacy technicians. SOPs must accurately reflect how the pharmacy actually operates. TI Pharmacy Consultancy advises on the compliance and governance implications of the new legislation — the SOP updates themselves are the pharmacy’s responsibility to implement.

Yes. The Human Medicines (Authorisation by Pharmacists and Supervision by Pharmacy Technicians) Order 2025 applies across Great Britain, including Wales. The GPhC, which regulates pharmacies in England, Wales and Scotland, is developing supporting standards and guidance applicable across all three nations. The NHS Terms of Service change confirmed by DHSC for 7 January 2026 was confirmed to apply to NHS community pharmacies without requiring changes to the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 in England — the equivalent position in Wales should be verified with NHS Wales.